Type 2 Diabetes News and Research

Latest Type 2 Diabetes News and Research

Weight loss can bring long-term health benefits for individuals with obesity, but not for lean people

Intentionally losing weight can bring long-term health benefits for individuals with obesity, regardless of the method or strategy they use, according to a study of almost 200,000 people.

27 Sep 2022

SARS-CoV-2 infections linked to increased incidence of new-onset type 1 diabetes in pediatric populations

A new study explored the association of SARS-CoV-2 infection with increased new-onset type 1 diabetes incidences among COVID-19 patients 18 years old and younger.

27 Sep 2022

Mortality prediction model for dementia patients may help guide decisions on end-of-life care

A mortality prediction model for older adults with dementia may help clinicians frame discussions with patients and their families relating to end-of-life care, such as at-home support and nursing homes.

26 Sep 2022

Study shows 72% increase in new diagnoses of type 1 diabetes in young COVID-19 patients

Children who were infected with COVID-19 show a substantially higher risk of developing type 1 diabetes (T1D), according to a new study that analyzed electronic health records of more than 1 million patients ages 18 and younger.

23 Sep 2022

Quinoa-based diet stabilizes blood sugar in older adults

A new study reports the ability of quinoa to normalize glucose metabolism in the body, particularly among the elderly with impaired glucose tolerance.

22 Sep 2022

Metabolic differences between early birds and night owls could help predict diabetes, heart disease risk

Are you an early bird or a night owl? Our activity patterns and sleep cycles could influence our risk of diseases, such as type 2 diabetes and heart disease.

21 Sep 2022

Large clinical trial compares four drugs commonly used to treat type 2 diabetes

In a large clinical trial that directly compared four drugs commonly used to treat type 2 diabetes, researchers found that insulin glargine and liraglutide performed the best of four medications approved by the U.S. Food and Drug Administration to maintain blood glucose levels in the recommended range.

21 Sep 2022

Early risers may have lower risk of diabetes and heart disease than late risers

A new study highlights that people with early chronotype use more fat during rest and exercise and exhibit more sensitivity to insulin. They remain more physically active throughout the day and have lower risk of type 2 diabetes.

21 Sep 2022

New device for diagnosing bone fragility approved for marketing in the Europe

A new device for diagnosing bone fragility invented by the University Hospitals of Geneva and the University of Geneva has been approved for marketing in the European Economic Area and Switzerland.

20 Sep 2022

High-fat diets drive the production of inflammatory immune cells in the bone marrow of mice

Scientists have shown that high-fat diets can cause rapid changes in the bone marrow of mice, driving the production of inflammatory immune cells, according to findings published today in eLife.

20 Sep 2022

Link between type 2 diabetes and UTIs explained

Lower immunity and recurring infections are common in type 1 and type 2 diabetes. Researchers at Karolinska Institutet in Sweden now show that the immune system of people with diabetes has lower levels of the antimicrobial peptide psoriasin, which compromises the urinary bladder's cell barrier, increasing the risk of urinary tract infection.

20 Sep 2022

Moderate consumption of tea linked to lower risk of developing type 2 diabetes

A systematic review and meta-analysis of 19 cohort studies involving more than 1 million adults from eight countries finds that moderate consumption of black, green or Oolong tea is linked to a lower risk of developing type 2 diabetes.

19 Sep 2022

Study establishes a direct link between disruption of circadian clocks and lipid changes in diabetics

A team from Geneva, Switzerland, shows that the disruption of lipid temporal profiles in type 2 diabetes stiffens the membrane of pancreatic endocrine cells, which could alter their function.

19 Sep 2022

Obese children who recently lost weight more likely to show hunger-related brain activity after a meal

Children with obesity, who have recently lost weight, are more likely to show hunger-related activity in their brains after a meal, according to research presented today at the 60th Annual European Society for Paediatric Endocrinology Meeting.

15 Sep 2022

Seven healthy lifestyle habits linked to lower risk of dementia in people with diabetes

A combination of seven healthy lifestyle habits including sleeping seven to nine hours daily, exercising regularly and having frequent social contact was associated with a lower risk of dementia in people with type 2 diabetes, according to a study published in the September 14, 2022, online issue of Neurology®, the medical journal of the American Academy of Neurology.

14 Sep 2022

Study explores the impact of genetic risk variants on overall disease burden and healthy life years

In a new study, researchers explored the genetic risk factors associated with various diseases to understand their impact on healthy life years.

14 Sep 2022

UC San Diego selected to lead components of the NIH Common Fund's Bridge2AI program

Researchers at University of California San Diego School of Medicine have been selected to lead components of the National Institutes of Health (NIH) Common Fund's Bridge to Artificial Intelligence (Bridge2AI) program.

13 Sep 2022

In vitro skeletal muscle models could lead to personalized medicine for type 2 diabetes

Abnormally high blood sugar (glucose) levels can result in Type 2 diabetes when things go awry with the body's skeletal muscle, which plays a key role in regulating glucose.

13 Sep 2022

A widening gap found in diabetes-related mortality between urban and rural areas in the USA

A new study published in Diabetologia (the journal of the European Association for the Study of Diabetes [EASD]) finds that there is a widening gap in diabetes-related mortality between urban and rural areas in the USA, and that reductions in mortality rates seen predominantly in urban areas have been mainly limited to female and older patients while outcomes in male and younger individuals worsened.

12 Sep 2022

Semaglutide appears to be an effective medication for treating obesity, study says

The risk of type 2 diabetes (T2D) is more than halved by weekly injections of new obesity drug semaglutide, according to new research being presented at the annual meeting of the European Association for the Study of Diabetes (EASD) in Stockholm, Sweden (19-23 Sept).

12 Sep 2022

Type 2 Diabetes News and Research

Latest Type 2 Diabetes News and Research

Weight loss can bring long-term health benefits for individuals with obesity, but not for lean people

SARS-CoV-2 infections linked to increased incidence of new-onset type 1 diabetes in pediatric populations

Mortality prediction model for dementia patients may help guide decisions on end-of-life care

Study shows 72% increase in new diagnoses of type 1 diabetes in young COVID-19 patients

Quinoa-based diet stabilizes blood sugar in older adults

Metabolic differences between early birds and night owls could help predict diabetes, heart disease risk

Large clinical trial compares four drugs commonly used to treat type 2 diabetes

Early risers may have lower risk of diabetes and heart disease than late risers

New device for diagnosing bone fragility approved for marketing in the Europe

High-fat diets drive the production of inflammatory immune cells in the bone marrow of mice

Link between type 2 diabetes and UTIs explained

Moderate consumption of tea linked to lower risk of developing type 2 diabetes

Study establishes a direct link between disruption of circadian clocks and lipid changes in diabetics

Obese children who recently lost weight more likely to show hunger-related brain activity after a meal

Seven healthy lifestyle habits linked to lower risk of dementia in people with diabetes

Study explores the impact of genetic risk variants on overall disease burden and healthy life years

UC San Diego selected to lead components of the NIH Common Fund's Bridge2AI program

In vitro skeletal muscle models could lead to personalized medicine for type 2 diabetes

A widening gap found in diabetes-related mortality between urban and rural areas in the USA

Semaglutide appears to be an effective medication for treating obesity, study says

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Scalable, Smart, and Accessible: The Future of Lab Automation

Healthy Beginnings, Hopeful Futures: A Conversation with WHO’s Dr. Allotey

Type 2 Diabetes News and Research

Latest Type 2 Diabetes News and Research

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Scalable, Smart, and Accessible: The Future of Lab Automation

Healthy Beginnings, Hopeful Futures: A Conversation with WHO’s Dr. Allotey

Newsletters you may be interested in